- Home
- SITC vs QSI Comparison
SITC vs QSI Comparison
Compare SITC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SITC
- QSI
- Stock Information
- Founded
- SITC 1965
- QSI 2013
- Country
- SITC United States
- QSI United States
- Employees
- SITC N/A
- QSI N/A
- Industry
- SITC Real Estate Investment Trusts
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- SITC Real Estate
- QSI Health Care
- Exchange
- SITC Nasdaq
- QSI Nasdaq
- Market Cap
- SITC 786.5M
- QSI 633.2M
- IPO Year
- SITC 1993
- QSI N/A
- Fundamental
- Price
- SITC $15.42
- QSI $2.24
- Analyst Decision
- SITC Hold
- QSI Buy
- Analyst Count
- SITC 9
- QSI 2
- Target Price
- SITC $39.03
- QSI $3.25
- AVG Volume (30 Days)
- SITC 1.4M
- QSI 60.4M
- Earning Date
- SITC 02-11-2025
- QSI 02-27-2025
- Dividend Yield
- SITC 6.75%
- QSI N/A
- EPS Growth
- SITC 757.51
- QSI N/A
- EPS
- SITC 13.71
- QSI N/A
- Revenue
- SITC $451,683,000.00
- QSI $2,266,000.00
- Revenue This Year
- SITC N/A
- QSI $193.90
- Revenue Next Year
- SITC N/A
- QSI $173.18
- P/E Ratio
- SITC $1.12
- QSI N/A
- Revenue Growth
- SITC N/A
- QSI 232.26
- 52 Week Low
- SITC $14.55
- QSI $0.61
- 52 Week High
- SITC $64.44
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- SITC 50.71
- QSI 49.02
- Support Level
- SITC $14.55
- QSI $1.85
- Resistance Level
- SITC $15.60
- QSI $2.68
- Average True Range (ATR)
- SITC 0.30
- QSI 0.83
- MACD
- SITC 0.11
- QSI -0.15
- Stochastic Oscillator
- SITC 82.38
- QSI 9.95
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.